SLC9A1 and breast carcinoma: We first examined the anti-proliferative effect of various PPIs on two aggressive and highly metastatic breast cancer cells, 4T1 and TS/A, namely, Amiloride and Cariporide as NHE1 inhibitors and Lansoprazole and Esomeprazole as V-ATPase inhibitors.